Osamu Nakashima
Overview
Explore the profile of Osamu Nakashima including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
152
Citations
3284
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Mizuochi S, Akiba J, Kondo R, Kusano H, Shioga T, Kondo K, et al.
Anticancer Res
. 2021 Dec;
42(1):449-457.
PMID: 34969755
Background/aim: Non-B non-C hepatocellular carcinomas (NBNC-HCCs) are larger than hepatitis virus-related HCCs. We conducted a clinicopathological study of patients who underwent curative NBNC-HCC resection, including proliferative activity assessments, such as...
12.
Harada H, Muta S, Kakuma T, Ukeda M, Ota S, Hirata M, et al.
PLoS One
. 2021 Oct;
16(10):e0258647.
PMID: 34673803
Background: Bispectral index (BIS) monitoring is a widely used non-invasive method to monitor the depth of anesthesia. However, in the event of surgeries requiring a frontal approach, placement of the...
13.
Kudo M, Kawamura Y, Hasegawa K, Tateishi R, Kariyama K, Shiina S, et al.
Liver Cancer
. 2021 Jul;
10(3):181-223.
PMID: 34239808
The Clinical Practice Manual for Hepatocellular Carcinoma was published based on evidence confirmed by the Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma along with consensus opinion among a Japan Society...
14.
Kudo M, Izumi N, Kokudo N, Sakamoto M, Shiina S, Takayama T, et al.
Hepatol Res
. 2021 May;
52(1):5-66.
PMID: 34050584
In the 22nd Nationwide Follow-up Survey of Primary Liver Cancer in Japan, data from 21 155 newly registered patients and 43 041 previously registered follow-up patients were compiled from 538...
15.
Kaibori M, Yoshii K, Kashiwabara K, Kokudo T, Hasegawa K, Izumi N, et al.
Hepatol Res
. 2021 May;
51(8):890-901.
PMID: 34041804
Aim: We reviewed the data of a nationwide follow-up survey to determine the impact of hepatitis C virus (HCV) infection on the outcomes of hepatectomy for mass-forming (MF) type, and...
16.
Kawaguchi Y, Hasegawa K, Hagiwara Y, De Bellis M, Famularo S, Panettieri E, et al.
Am J Gastroenterol
. 2021 Apr;
116(8):1698-1708.
PMID: 33900211
Introduction: Most studies predicting survival after resection, transarterial chemoembolization (TACE), and ablation analyzed diameter and number of hepatocellular carcinomas (HCCs) as dichotomous variables, resulting in an underestimation of risk variation....
17.
Akiba J, Yoshida T, Sadashima E, Murata K, Matsui T, Yamagishi S, et al.
Anticancer Res
. 2021 Mar;
41(3):1203-1212.
PMID: 33788711
Background/aim: Hepatocellular carcinoma (HCC) remains one of the biggest medical issues. Pigment epithelial-derived factor (PEDF) is a glycoprotein that belongs to the superfamily of serine protease inhibitors. PEDF interacts with...
18.
Kudo M, Izumi N, Kokudo N, Sakamoto M, Shiina S, Takayama T, et al.
Hepatol Res
. 2020 Dec;
51(4):355-405.
PMID: 33382910
In the 21st Nationwide Follow-up Survey of Primary Liver Cancer in Japan, data from 22,134 new patients and 41,956 previously followed patients were compiled from 546 institutions over a 2-year...
19.
Aoki T, Kubota K, Kubo S, Eguchi S, Izumi N, Kokudo N, et al.
World J Surg
. 2020 Oct;
45(2):607-614.
PMID: 33104834
Background: Non-curative (debulking) hepatic resection for hepatocellular carcinoma (HCC) is occasionally applied for selected cases with bulky tumors or for oncologic emergency cases; however, the clinical usefulness of this procedure...
20.
Hisaka T, Sakai H, Sato T, Goto Y, Nomura Y, Fukutomi S, et al.
Anticancer Res
. 2020 Jul;
40(8):4695-4700.
PMID: 32727794
Background/aim: We investigated the anti-proliferative effect of quercetin on liver cancer cell lines. Materials And Methods: Thirteen liver cancer cell lines were cultured followed by treatment with varying concentrations of...